Clay Alspach, J.D., is a principal at Leavitt Partners based in Washington, D.C. Alspach specializes in federal health care policy and advocacy related to the FDA, Medicare, Medicaid, private health insurance and digital health. Prior to joining Leavitt Partners, Alspach served as Chief Health Counsel for Chairman Fred Upton of the U.S. House of Representatives Energy and Commerce Committee. During seven years with the committee, he managed, provided strategic direction, and served as the principal representative for the committee on all of its health care-related work. Alspach spearheaded legislative initiatives that successfully reformed the SGR (MACRA), reauthorized FDA user fees (FDASIA), and established a national system for drug supply chain security (Drug Quality and Security Act). Alspach also led the committee’s legislative accomplishments on biopreparedness and security, public and private medical research, controlled substance and DEA matters, and the 21st Century Cures Act. Prior to this service for the committee, Alspach clerked for the Honorable Ronald L. Buckwalter of the U.S. District Court for the Eastern District of Pennsylvania and worked as a litigator in private law practice. He also worked as a legislative clerk at the committee from 1999 to 2000 under Chairman Thomas J. Bliley (R-VA). Alspach received his bachelors of arts cum laude from the University of Richmond and holds a juris doctor from the University of Texas at Austin.
Adimika Arthur, MPH, is an experienced clinical epidemiologist and hospital/health system executive. She uniquely brings her population health, public hospital expertise and focus on improving health equity and access to advancing quality care for vulnerable populations to her daily advocacy. She serves as the founding Executive Director for HealthTech for Medicaid (HT4M). HT4M is a collaborative convening of payers, providers, policymakers and innovative entrepreneurs rapidly advancing health equity and improvement of the Medicaid program on a national scale. Seen as a market-enabler, HT4M believes that a strategic injection of technology and innovation into the Medicaid ecosystem is essential. This bold, action-oriented, and inclusive network is working to ensure critical novel technologies reach Medicaid enrollees and other traditionally vulnerable and disadvantaged populations. Arthur has worked at many hospital systems including Alameda County Medical Center, University of California at San Francisco and Sutter Health. In her role as a hospital executive, her specialties included acute and children’s hospital and ambulatory care operations. She is skilled in turn-around environments including healthcare cost containment and revenue cycle enhancement engaging clinicians and staff without compromising patient care or quality. She is passionate about leadership development and is motivated to create successful pathways to further women’s advancement into C-suite roles in the healthcare delivery system and on hospital boards. She consistently mentors and inspires women to make meaningful changes in leadership while promoting health equity and making conditions better for vulnerable populations. She is an ardent champion for providing leadership on planning, development, and implementation of strategies and initiatives to better understanding and improve the US Medicaid program. She was one of the authors of the 2005 California 1115 waiver Medicaid expansion grants for Alameda County Medi-Cal program, an investment of over $50 Million dollars into safety-net care improvements. This paved the way for Medicaid expansion in California (before the ACA) and is the largest healthcare award to date in Alameda County. Arthur is a public health leader, hospital executive and humanitarian who holds numerous certificates and awards. She combines her love of mentoring, servant leadership and service by maintaining non-profit board roles for many organizations including CALHIPSO and many others focusing on the promoting the pipeline of underrepresented youth getting into the full spectrum of health careers. She received her Bachelors in Science (BS) in Biochemistry from Clark Atlanta University in Atlanta, Georgia, her Master’s Degree in Public Health) in Epidemiology and Health Systems from the University of Washington and was educated at Boston University School of Medicine.
Caterina Bulagarella, Ph.D., M.A., is an expert in organizational culture and behavioral ethics. She is the co-founder and managing director of Be Thread, a platform of solutions based on behavioral science insights designed to drive organizational, group and individual level change. She is an influencer in the field of organizational behavior where she’s conducted extensive research on processes of culture change, ethical risk, decision-making bias, and self-regulation. As a strategic advisor to the C-suite, Dr. Bulgarella has tackled a variety of challenges, including conduct-based risk and culture, internal innovation, and leadership development. Dr. Bulgarella holds a Ph.D. in Organizational Psychology and Master’s degrees in Organizational and Personnel Psychology from New York University. She serves on the I/O psychology Master’s program at New York University (NYU) and is a member of Ethical Systems’ core research team. She regularly contributes to several publications with behavioral insights on culture, ethics, and leadership.
Jodi G. Daniel, J.D., MPH, is a partner in Crowell & Moring’s Health Care Group and a member of the group’s Steering Committee. She is also a director at C&M International (CMI), an international policy and regulatory affairs consulting firm affiliated with Crowell & Moring. She leads the firm’s Digital Health Practice and provides strategic, legal, and policy advice to all types of health care and technology clients navigating the dynamic regulatory environment related to technology in the health care sector to help them achieve their business goals. Prior to joining Crowell & Moring, Daniel was the founding director of the Office of Policy in the Office of the National Coordinator for Health Information Technology (ONC), U.S. Department of Health and Human Services (HHS) for a decade after serving in the Office of the General Counsel (OGC) at HHS for five years. At HHS, Daniel helped spearhead important changes in health information privacy and health information technology to improve health care for consumers nationwide. She was also one of the key drafters of the original Health Insurance Portability and Accountability Act (HIPAA) Privacy Rules and Enforcement Rules and developed the Nationwide Privacy and Security Framework for Electronic Exchange of Health Information. As former director at ONC, she led the agency’s prominent federal advisory committees to build consensus on health IT standards and policy and established national health IT policy in areas including privacy, security, consumer e-health, health IT safety and oversight, and connecting health care payment and health IT. Daniel established ONC’s regulatory capacity and led the development of health IT standards and certification regulations. She worked across many federal agencies to develop the Federal Health IT Strategic Plan and coordinate policy, including with the Centers for Medicare and Medicaid Services (CMS) on the “meaningful use” of electronic health records, with Food and Drug Administration (FDA) on the safety of health IT, with the Drug Enforcement Agency (DEA) on legalizing electronic prescribing of controlled substances, with the Federal Trade Commission (FTC) on competition and health IT, with the Substance Abuse Mental Health Services Administration (SAMHSA) on integrating behavioral health and physical health, and with the White House Office of National Drug Control Policy (ONDCP) regarding opioid abuse. She also developed the Health Information Security and Privacy Collaboration, working with 42 state and territorial governments to address variation in privacy laws and challenges presented by electronic health information exchange through multi-state collaboration. Daniel formed the State Alliance for e-Health in collaboration with the National Governors’ Association, to promote e-Health, including electronic prescribing and multi-state licensure for telemedicine. She also represented the U.S. Government in presentations and engagements with foreign governments. As the first senior counsel for health information technology at HHS, Daniel developed the foundational legal strategies and coordinated all legal advice regarding health IT for HHS, founded and chaired the health information technology practice group within OGC, and worked closely with CMS in the development of the e-prescribing regulations and the Stark and anti-kickback rules regarding e-prescribing and electronic health records. Daniel began her career at a large insurance company advising employers on managed care and group health benefits.
Susan dosReis, Ph.D., is a professor and vice chair of Research in the Department of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy. She received a bachelor of science in pharmacy from the University of Rhode Island School of Pharmacy, a doctorate in pharmacoepidemiology from the University of Maryland Graduate School, and she completed a postdoctoral fellowship in child mental health services from the Johns Hopkins Bloomberg School of Public Health. Prior to this current appointment, she was on the faculty of the Johns Hopkins University School of Medicine, Division of Child and Adolescent Psychiatry. Federally-funded research grants through the National Institute of Mental Health (NIMH) and the Patient Centered Outcomes Research Institute (PCORI) have led to a foundation of research on psychotropic medication use among children and adolescents. Over the past 20 years, she developed a program of pediatric pharmacoepidemiology and outcomes research. Her primary authored and co-authored publications address health system and patient- and family-centered factors that affect psychotropic use for youth treated in community outpatient settings. She has expertise in stated preference methods to evaluate caregiver trade-offs in decision making with regard to medication use in their children. She has used mixed methods to understand health disparities in socioeconomically disadvantaged populations. As Director of the Patient-Driven Values in Healthcare Evaluation (PAVE) Center, she is applying novel methods to better understand disparities in treatment decisions from a variety of patient groups, and in particular the underserved communities.
Lisa Bo Feng, DrPH, oversees the Cystic Fibrosis Foundation’s efforts to ensure people with CF have coverage and access to high-quality, individualized care. Dr. Feng directs the Foundation’s engagements with payers and government officials on issues related to affordability and accessibility of CF care via adequate insurance coverage, especially in Medicaid. She also is a leader in the Foundation’s efforts to develop innovative care and payment mechanisms that efficiently, effectively, and consistently provide high-value CF care. Prior to joining the Foundation, Dr. Feng led the Value and Coverage program at FasterCures, a center of the Milken Institute. She has also worked extensively on programs funded by the Center for Medicare and Medicaid Innovation and the Robert Wood Johnson Foundation. Dr. Feng is a health services researcher and has published on topics such as primary care quality, electronic health records, and emergency department care. She received her doctorate in health policy at the George Washington University Milken Institute School of Public Health.
Kym Martin, MBA, is a business performance advisor at Insperity who leverages her professional expertise as a business development leader and personal experience as a 4-time cancer survivor to help health care stakeholders understand and solve complex, real-world patient and consumer challenges. Martin’s a nationally-recognized, keynote speaker and thought leader on consumer: engagement, empowerment and partnerships. With Insperity, she draws on her health care insights when advising executives across industries on employer risk mitigation, employee engagement and “Best Places to Work” culture.
Mark McClellan, MD, Ph.D., is director and Robert J. Margolis, M.D., Professor of Business, Medicine and Health Policy at the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence and more effective drug and device innovation. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. He is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Health Care and Seer, and is co-chair of the Accountable Care Learning Collaborative and the Guiding Committee for the Health Care Payment Learning and Action Network.
Purva Rawal, Ph.D., is a principal at CapView Strategies where she develops evidence-based public policy and business strategies for providers, health systems, life sciences companies, and coalitions, and conducts policy research on health system transformation and sustainability issues. She is also an Adjunct Assistant Professor at Georgetown University, and is an active writer and public speaker. In 2016, she published a book, The Affordable Care Act: Examining the Facts. Previously, Dr. Rawal served as professional staff on the Senate Budget Committee during the passage of the Affordable Care Act, and as the health and social policy advisor to Sen. Joseph Lieberman (I-CT). She was also a Director in the Health Insurance and Reform Practice at Avalere Health. She began her health policy career as a Christine Mirzayan Science and Technology Fellow at the National Academy of Sciences and as a Congressional Fellow for the Society for Research on Child Development and the American Association for the Advancement of Science. Dr. Rawal received her BA and PhD from Northwestern University
Josh Seidman, Ph.D., MHS, is the managing director of Avalere. He advises clients on health delivery and payment innovation with a focus on using information technology to guide value-based care models. He applies his background in quality, health IT, and patient engagement to accountable care delivery system transformation and new payment models. Prior to joining Avalere, Dr. Seidman was a managing director at Evolent Health, where he supported large delivery system clients in quality measurement and performance improvement around clinical transformation, patient engagement, and population health management programs. Prior to that, Dr. Seidman was a director of Meaningful Use at the Department of Health and Human Services in the Office of the National Coordinator for Health Information Technology, the founding president of the Center for Information Therapy, and director of Measure Development at NCQA. Dr. Seidman holds a PhD and an MHS in health policy and management from The Johns Hopkins Bloomberg School of Public Health and a BA from Brown University. Dr. Seidman is a past president of the Society for Participatory Medicine and was a William B. Ziff Fellow for patient engagement with the Center for Advancing Health.
David Steinhorn, M.D., is a 35-year veteran pediatric ICU attending physician and pioneer in developing pediatric palliative and hospice care over the last 25 years. He currently works at the Children’s National Medical Center. He received his MD degree from the University of Minnesota in 1979 with post-graduate training in Virginia, Minnesota and New York. He was mentored in bioethics by Dr. Arthur Caplan while in Minnesota and served as an ethics consultant for 10 before moving into palliative care. In addition to a productive laboratory research career in respiratory failure, he developed innovative palliative care programs at the children’s hospitals in Buffalo, NY, Chicago, and Washington, DC. Dr. Steinhorn’s focus is on quality of life, wise decision making for seriously children, and supporting the human spirit within the frail body through application of transpersonal healing work.
Tim Wilson, CFA, he is the CFO and strategy lead at Quil where he brings years of investment and business building expertise across the energy and healthcare sectors to help drive Quil’s health innovation vision. Wilson has focused his career on understanding and driving change at incumbent, broad-reaching industries that impact people’s everyday lives. Tim describes his professional superpower as “curiosity.”
Jennifer Bright, MPA., is president of Momentum Health Strategies where he contributes 20+ years of experience accelerating policy and quality improvement initiatives that benefit the care and experience of patients. Her work advances patient engagement in research and care delivery, primary/behavioral health care integration, and prevention strategies. She has advised patient and provider organizations in strategic planning and policy implementation, led the creation of a quality improvement resource on antibiotic stewardship for the National Quality Forum and currently advises several organizations regarding improving methods in value measurement and patient information frameworks. Past accomplishments at the Society for Healthcare Epidemiology of America (SHEA) and Mental Health America include policy and practice change regarding vaccination, antimicrobial stewardship and healthcare-associated infection (HAI) prevention, and state parity and consumer protection laws for individuals with mental health disorders, respectively. She holds degrees from Trinity College, Washington, D.C. and The George Washington University.
Sarah J. Dash, MPH, is the president and chief executive officer at the Alliance for Health Policy. She drives the mission and vision of the Alliance, as well as advances and maintains the reputation of the organization as the leading nonpartisan resource for policymakers and health leaders in an evolving health policy environment. Sarah joined the Alliance in 2014 as the vice president for policy and became president and CEO in May 2017. Sarah has long been an influential force in shaping health policy, having served as a senior aide on Capitol Hill and as a member of the research faculty at the Georgetown University Health Policy Institute’s Center on Health Insurance Reforms. Sarah holds a master’s degree in public health from the Yale School of Public Health and a bachelor’s degree in chemistry and literature from MIT. Sarah also holds an Executive Certificate in Nonprofit Management from Georgetown University.
Sung Hee Choe, MPH, is a director at FasterCures, a center of the Milken Institute, where she focuses on ways to create pathways for biomedical innovation. Prior to joining FasterCures, she was a Managing Director at Avalere Health. In this role, Choe focused on a broad range of healthcare issues, with an emphasis on policies that aim to accelerate access to new treatments and to elevate the patient voice across the care continuum. At Avalere, she also oversaw the firm’s content strategy, which involved leading new content development, identifying emerging trends and topics, and building consensus around research initiatives. Prior to Avalere, Choe spent a decade in the financial services industry, most recently as a Vice President at BNY Mellon Investment Management. At BNY Mellon, Choe was the lead healthcare analyst for a small-cap growth fund, for which she researched pharmaceutical, biotechnology, and medical device companies to identify investment opportunities.